155 related articles for article (PubMed ID: 20364539)
1. Seroprevalence and correlates of HIV and HCV among injecting drug users in Edmonton, Alberta.
Plitt SS; Gratrix J; Hewitt S; Conroy P; Parnell T; Lucki B; Pilling V; Anderson B; Choudri Y; Archibald CP; Singh AE
Can J Public Health; 2010; 101(1):50-5. PubMed ID: 20364539
[TBL] [Abstract][Full Text] [Related]
2. Unsafe injection and sexual risk behavior among injecting drug users in Georgia.
Chikovani I; Bozicevic I; Goguadze K; Rukhadze N; Gotsadze G
J Urban Health; 2011 Aug; 88(4):736-48. PubMed ID: 21717253
[TBL] [Abstract][Full Text] [Related]
3. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
[TBL] [Abstract][Full Text] [Related]
6. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
[TBL] [Abstract][Full Text] [Related]
7. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
[TBL] [Abstract][Full Text] [Related]
8. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
[TBL] [Abstract][Full Text] [Related]
9. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
11. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
12. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
[TBL] [Abstract][Full Text] [Related]
13. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
14. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
Yen YF; Yen MY; Su LW; Li LH; Chuang P; Jiang XR; Deng CY
BMC Public Health; 2012 Dec; 12():1066. PubMed ID: 23227904
[TBL] [Abstract][Full Text] [Related]
15. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
16. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India.
Basu D; Sharma AK; Gupta S; Nebhinani N; Kumar V
Indian J Med Res; 2015 Sep; 142(3):311-6. PubMed ID: 26458347
[TBL] [Abstract][Full Text] [Related]
18. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.
Miller CL; Wood E; Spittal PM; Li K; Frankish JC; Braitstein P; Montaner JS; Schechter MT
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):743-9. PubMed ID: 15167294
[TBL] [Abstract][Full Text] [Related]
19. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil.
de Carvalho HB; Mesquita F; Massad E; Bueno RC; Lopes GT; Ruiz MA; Burattini MN
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):84-92. PubMed ID: 8624766
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
